Esperion Therapeutics, Inc.

Direct answer

Esperion Therapeutics, Inc. is publicly traded on NASDAQ under the ticker ESPR.

Esperion Therapeutics, Inc. operates as a pharmaceutical firm, concentrating on the development and commercialization of treatments for individuals with high levels of low-density lipoprotein (LDL) cholesterol. The company's flagship pharmaceutical products are NEXLETOL (bempedoic acid) and NEXLIZET (a tablet combining bempedoic acid and ezetimibe), prescribed for managing conditions such as atherosclerotic...

Can you invest in Esperion Therapeutics, Inc.?

Yes. Esperion Therapeutics, Inc. trades publicly on NASDAQ as ESPR.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Esperion Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.